Advertisement
Screener

AMYLIN PHARMACEUTICALS INC Operating Cash Flow

AMYLIN PHARMACEUTICALS INC Operating Cash Flow

AMYLIN PHARMACEUTICALS INC reported Operating Cash Flow of -$82.50 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-08-03

  • AMYLIN PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was $10.86M, a 39.32% decline year-over-year.
  • AMYLIN PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was -$93.36M, a 504.11% decline year-over-year.
  • AMYLIN PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was $19.34M, a 297.80% increase year-over-year.
  • AMYLIN PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was $27.97M.
  • AMYLIN PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2011 was $88.30M.
  • AMYLIN PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2010 was -$38.72M, a 294.36% decline from fiscal 2009.
  • AMYLIN PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2009 was $19.92M.
  • AMYLIN PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2008 was -$19.51M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2012-06-30$10.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
-$82.50M
10-Q · filed 2012-08-03
-$63.16M
derived: sum of 3 quarters · filed 2012-08-03
-$35.19M
derived: sum of 4 quarters · filed 2012-08-03
2012-03-31-$93.36M
10-Q · filed 2012-05-07
-$74.02M
derived: sum of 2 quarters · filed 2012-05-07
-$46.05M
derived: sum of 3 quarters · filed 2012-05-07
-$28.16M
derived: sum of 4 quarters · filed 2012-08-03
2011-12-31$19.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22
$47.31M
derived: sum of 2 quarters · filed 2012-02-22
$65.20M
derived: sum of 3 quarters · filed 2012-08-03
$88.30M
10-K · filed 2012-02-22
2011-09-30$27.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28
$45.86M
derived: sum of 2 quarters · filed 2012-08-03
$68.96M
10-Q · filed 2011-10-28
$73.82M
derived: sum of 4 quarters · filed 2012-08-03
2011-06-30$17.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
$40.99M
10-Q · filed 2012-08-03
$45.85M
derived: sum of 3 quarters · filed 2012-08-03
$32.95M
derived: sum of 4 quarters · filed 2012-08-03
2011-03-31$23.10M
10-Q · filed 2012-05-07
$27.96M
derived: sum of 2 quarters · filed 2012-05-07
$15.06M
derived: sum of 3 quarters · filed 2012-05-07
$22.88M
derived: sum of 4 quarters · filed 2012-05-07
2010-12-31$4.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22
-$8.04M
derived: sum of 2 quarters · filed 2012-02-22
-$222.00K
derived: sum of 3 quarters · filed 2012-02-22
-$38.72M
10-K · filed 2012-02-22
2010-09-30-$12.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28
-$5.08M
derived: sum of 2 quarters · filed 2011-10-28
-$43.59M
10-Q · filed 2011-10-28
$47.97M
derived: sum of 4 quarters · filed 2012-02-22
2010-06-30$7.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08
-$30.68M
10-Q · filed 2011-08-08
$60.87M
derived: sum of 3 quarters · filed 2012-02-22
$84.39M
derived: sum of 4 quarters · filed 2012-02-22
2010-03-31-$38.50M
10-Q · filed 2011-05-05
$53.05M
derived: sum of 2 quarters · filed 2012-02-22
$76.57M
derived: sum of 3 quarters · filed 2012-02-22
2009-12-31$91.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22
$115.07M
derived: sum of 2 quarters · filed 2012-02-22
$19.92M
10-K · filed 2012-02-22
2009-09-30$23.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08
-$71.63M
10-Q · filed 2010-11-08
2009-06-30-$95.15M
10-Q · filed 2010-08-05
2008-12-31-$19.51M
10-K · filed 2011-02-25